Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
For injuries and gut repair, the progress often holds
Addressing Regulatory Concerns The current "unapproved drug" status by the FDA and the bans by anti-doping agencies highlight the significant regulatory hurdles BPC-157 faces
Ipamorelin secretagogue data) BPC157 or TB500 Supports recovery during calorie deficits, protecting muscle and tendon health
Growth Hormone Releasing Hormones (GHRHs): CJC-1295, Sermorelin Enhance the natural production of GH, supporting tissue repair and overall body rejuvenation
The lyophilization process preserves peptide stability and allows researchers to reconstitute the compound for controlled in vitro experimentation
dose-dependent GI adverse events (nausea, vomiting) similar to other amylin analogues Exposure: Dose-proportional increases in Cmax and AUC Gastric Effects: Dose-dependent slowing of gastric emptying confirmed via paracetamol absorption test Appetite Suppression: Reduced ad libitum food intake at doses 1.2 mg Clinical Significance: Established feasibility of once-weekly dosing and identified dose range for Phase 2 studies
US$ 21.34
US$ 25.96
US$ 21.31
US$ 20.63
US$ 27.15
US$ 26.33
US$ 28.87
